Dupilumab for EoE: How Is it Improving Treatment?
The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.
Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.
Lifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.
The study is thought to be the first comprehensive analysis to evaluate NMRF as a treatment for acne, according to the authors.
Among older adults with normal blood pressure, replacing table salt with salt substitute reduced the incidence of hypertension vs a usual salt group, in the DECIDE-Salt trial.
In patients presenting at thrombectomy-capable stroke centers, the benefit associated with thrombolysis before thrombectomy was time dependent, new data suggested.